Fox Business
Markets
Published September 30, 2016 10:38am EDT | Updated November 25, 2017 1:54am EST

The Crazy Backstory Around Sarepta Therapeutics' Game-Changing Drug Approval

  • Comments
By Motley Fool Staff Fool.com
Personal Finance
  • Mortgages
  • Student Loans
  • Credit Cards
  • Personal Loans
  • Savings
  • Insurance
  • 401k
  • Retirement
  • Tax Planning
Economy
  • Government Spending
  • Money & Policy
  • Small Business
Markets
  • Stocks
  • US Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • ETFs
  • Business Leaders
  • Industries
  • Retail
  • Pre-Markets
  • Mutual Funds
Watchlist
Lifestyle
  • Entertainment
  • Rich & Famous
  • Travel
  • Cars
  • Airplanes
  • Food & Drinks
  • Arts
Real Estate
  • Personal
  • Commercial
  • Luxury Properties
Tech
  • Digital
  • Social Media
  • Gadgets
  • Business Tech
  • Healthcare Tech
  • Future Tech
  • AI
  • Space
Sports
  • NFL
  • NBA
  • MLB
  • NASCAR
  • Boxing
  • Soccer
  • Golf
  • Tennis
Opinion
Video
About
  • Channel Finder
  • Jobs
  • Terms of Use
  • Privacy Policy
  • FAQ
  • Media Relations
  • Corporate Information
  • Closed Captioning Policy
  • Accessibility Statement
  • Fox News
  • Fox Nation
  • Fox Business Go
  • Apps & Products
  • Facebook
  • Twitter
  • RSS
Fox Business
  • Terms of Use
  • New Privacy Policy
  • Your Privacy Choices
  • Help
  • Closed Captioning Policy

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. All market data delayed 20 minutes.